Reports for APOTEX INC

Formerly known as AA PHARMA INC

Company Name
APOTEX INC

Shortage reports

Actual shortage:

220 (7%)

Anticipated shortage:

0 (0%)

Avoided shortage:

10 (0%)

Resolved:

3124 (93%)

3354

Discontinuation Reports

To be discontinued:

26 (7%)

Discontinued:

343 (93%)

Reversed:

0 (0%)

369

145 (4%)

73 (30%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-GLICLAZIDE MR 30MG TABLET (EXTENDED-RELEASE) Resolved 2023-01-26 2023-02-23 182382
APO-GLICLAZIDE MR 30MG TABLET (EXTENDED-RELEASE) Resolved 2020-10-28 2021-02-16 127342
APO-GLICLAZIDE MR 60MG TABLET (EXTENDED-RELEASE) Resolved 2024-10-04 2025-01-10 239373
APO-GLICLAZIDE MR 60MG TABLET (EXTENDED-RELEASE) Resolved 2023-06-09 2023-09-22 194571
APO-GLICLAZIDE MR 30MG TABLET (EXTENDED-RELEASE) Resolved 2025-01-30 2025-03-28 249074
APO-GLICLAZIDE MR 30MG TABLET (EXTENDED-RELEASE) Resolved 2023-10-06 2024-02-16 206563
APO-GLICLAZIDE MR 60MG TABLET (EXTENDED-RELEASE) Resolved 2020-11-26 2020-12-17 128933
APO-GLICLAZIDE MR 60MG TABLET (EXTENDED-RELEASE) Resolved 2024-01-26 2024-05-31 217481
APO-GLICLAZIDE MR 60MG TABLET (EXTENDED-RELEASE) Resolved 2017-11-21 2018-03-21 29960
APO-GLICLAZIDE MR 60MG TABLET (EXTENDED-RELEASE) Resolved 2025-02-06 2025-04-04 249766
APO-GLICLAZIDE MR 60MG TABLET (EXTENDED-RELEASE) Resolved 2020-07-29 2020-07-30 121325
APO-GLIMEPIRIDE 4MG TABLET Resolved 2017-11-28 2019-09-21 31007
APO-GLIMEPIRIDE 2MG TABLET Resolved 2018-07-11 2019-09-21 55281
APO-GLIMEPIRIDE 1MG TABLET Resolved 2017-12-12 2019-09-21 32536
APO-GUANFACINE XR 3MG TABLET (EXTENDED-RELEASE) Resolved 2023-12-22 2024-01-12 214220
APO-GUANFACINE XR 2MG TABLET (EXTENDED-RELEASE) Resolved 2023-12-08 2024-01-12 212949
APO-GUANFACINE XR 3MG TABLET (EXTENDED-RELEASE) Resolved 2022-06-12 2022-07-28 162475
APO-GUANFACINE XR 2MG TABLET (EXTENDED-RELEASE) Resolved 2023-12-22 2024-01-12 214232
APO-GUANFACINE XR 1MG TABLET (EXTENDED-RELEASE) Resolved 2022-07-11 2022-08-12 164378
APO-GUANFACINE XR 4MG TABLET (EXTENDED-RELEASE) Resolved 2023-12-15 2024-01-12 213559
Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-DILTIAZ TZ 180MG CAPSULE (EXTENDED RELEASE) Discontinued 2017-03-13 2017-03-13 1069
APO-DIPYRIDAMOLE-FC TAB 25MG 25MG TABLET Discontinued 2019-12-20 2020-07-30 101888
APO-DIPYRIDAMOLE-FC TAB 50MG 50MG TABLET Discontinued 2019-12-20 2020-07-30 101891
APO-DIPYRIDAMOLE-FC TAB 75MG 75MG TABLET Discontinued 2019-12-20 2019-12-21 101880
APO-DIVALPROEX 250MG TABLET (ENTERIC-COATED) Discontinued 2018-09-07 2018-09-15 60438
APO-DOCUSATE SODIUM 100MG CAPSULE Discontinued 2018-02-23 2019-03-29 40733
APO-DONEPEZIL 10MG TABLET Discontinued 2018-09-07 2018-09-15 60443
APO-DONEPEZIL 10MG TABLET Discontinued 2018-09-07 2018-09-15 60447
APO-DONEPEZIL 5MG TABLET Discontinued 2018-09-07 2018-10-12 60450
APO-DONEPEZIL 5MG TABLET Discontinued 2018-09-07 2019-02-13 60453
APO-DOXY CAP 100MG 100MG CAPSULE Discontinued 2018-09-07 2018-09-29 60459
APO-DOXY TABS 100MG 100MG TABLET Discontinued 2017-03-30 2018-02-05 4707
APO-ENALAPRIL TAB 10MG 10MG TABLET Discontinued 2018-09-07 2018-12-05 60462
APO-ENALAPRIL TAB 20MG 20MG TABLET Discontinued 2018-09-07 2018-11-19 60465
APO-ENALAPRIL TAB 5MG 5MG TABLET Discontinued 2018-09-07 2018-11-02 60468
APO-ESCITALOPRAM 10MG TABLET Discontinued 2018-09-07 2018-11-16 60474
APO-ESCITALOPRAM 20MG TABLET Discontinued 2018-09-07 2018-09-15 60471
APO-EXEMESTANE Discontinued 2019-06-12 2019-06-12 86552
APO-FAMOTIDINE TAB 20MG USP Discontinued 2018-09-07 2018-09-15 60477
APO-FAMOTIDINE TAB 40MG USP Discontinued 2018-09-07 2018-09-15 60480

Showing 141 to 160 of 369